The Case For Novel Funding Models In Digitalization Of Devices
Executive Summary
Digitalization can offer many benefits to European health care systems, but how does this look from a payer’s perspective? A health insurance expert has made the case for bundled reimbursement models based on shared risk and investment.
You may also be interested in...
EU Lacks Reimbursement For AI-Based Medtech, Warn Manufacturers
Medtech products based on artificial intelligence (AI) have the potential to transform the treatment paradigm in Europe, but manufacturers say reimbursement challenges are hindering product development.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
EU Needs Market Access Improvements Beyond New HTA Regulation
While the EU Health Technology Assessment Regulation could reduce divergence in reimbursement decisions made across member states, many national-level HTA hurdles and challenges will remain, market access experts from EFPIA say.